Meissner
The highly fragmented US cell therapy market requires hyper-customized, small-volume closed systems (e.g., Meissner) to safely handle autologous patient samples.
- Country
- United States
Commercial
One-Touch
Coverage
| CN | EU | US | |
|---|---|---|---|
| consumables | ✓ | ✓ | ✓ |
Regulatorsfdaema
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Single-use assemblies | consumables | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.